{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:54:14Z","timestamp":1793717654305,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372313"],"award-info":[{"award-number":["82372313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072371"],"award-info":[{"award-number":["82072371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102482"],"award-info":[{"award-number":["82102482"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302931"],"award-info":[{"award-number":["82302931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272390"],"award-info":[{"award-number":["82272390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Extrahepatic cholangiocarcinoma (ECC), a highly malignant type of cancer with increasing incidence, has a poor prognosis due to limited treatment options. Based on genomic analysis of ECC patient samples, here we report that aldo-keto reductase family 1 member C1 (AKR1C1) is highly expressed in human ECC tissues and closely associated with ECC progression and poor prognosis. Intriguingly, we show that inducible AKR1C1 knockdown triggers ECC cells to undergo ferroptosis. Mechanistically, AKR1C1 degrades the protein stability of the cytochrome P450 family member CYP1B1, a newly discovered mediator of ferroptosis, via ubiquitin-proteasomal degradation. Additionally, AKR1C1 decreases CYP1B1 mRNA level through the transcriptional factor aryl-hydrocarbon receptor (AHR). Furthermore, the AKR1C1\u2013CYP1B1 axis modulates ferroptosis in ECC cells via the cAMP\u2013PKA signaling pathway. Finally, in a xenograft mouse model of ECC, AKR1C1 depletion sensitizes cancer cells to ferroptosis and synergizes with ferroptosis inducers to suppress tumor growth. Therefore, the AKR1C1\u2013CYP1B1\u2013cAMP signaling axis is a promising therapeutic target for ECC treatment, especially in combination with ferroptosis inducers.<\/jats:p>","DOI":"10.1038\/s41418-024-01407-1","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:02:41Z","timestamp":1730304161000},"page":"506-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The AKR1C1\u2013CYP1B1\u2013cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma"],"prefix":"10.1038","volume":"32","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-8000","authenticated-orcid":false,"given":"Hongkun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-2556","authenticated-orcid":false,"given":"Zhibin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1332-0783","authenticated-orcid":false,"given":"Wenlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-1421","authenticated-orcid":false,"given":"Zhexiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-4771","authenticated-orcid":false,"given":"Minghui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-7345","authenticated-orcid":false,"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"1407_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin J, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1407_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, et al. Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2023;20:349\u201365. https:\/\/doi.org\/10.1038\/s41575-022-00741-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1407_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21:671\u201384. https:\/\/doi.org\/10.1016\/S1470-2045(20)30109-1.","journal-title":"Lancet Oncol"},{"key":"1407_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2023.01.027","volume":"78","author":"M Cadamuro","year":"2023","unstructured":"Cadamuro M, Al-Taee A, Gonda TA. Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma. J Hepatol. 2023;78:1063\u201372. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.027.","journal-title":"J Hepatol"},{"key":"1407_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41551-020-0583-0","volume":"4","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhang H, Zhou N, Xu P, Wang J, Gao Y, et al. Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma. Nat Biomed Eng. 2020;4:743\u201353. https:\/\/doi.org\/10.1038\/s41551-020-0583-0.","journal-title":"Nat Biomed Eng"},{"key":"1407_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/14728222.2021.1882998","volume":"25","author":"C Louis","year":"2021","unstructured":"Louis C, Edeline J, Coulouarn C. Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy. Expert Opin Ther Targets. 2021;25:153\u201362. https:\/\/doi.org\/10.1080\/14728222.2021.1882998.","journal-title":"Expert Opin Ther Targets"},{"key":"1407_CR7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s10620-015-3953-9","volume":"61","author":"K Urabe","year":"2016","unstructured":"Urabe K, Murakami Y, Kondo N, Uemura K, Hashimoto Y, Nakagawa N, et al. Nerve growth factor expression is not associated with perineural invasion in extrahepatic cholangiocarcinoma. Dig Dis Sci. 2016;61:774\u201384. https:\/\/doi.org\/10.1007\/s10620-015-3953-9.","journal-title":"Dig Dis Sci"},{"key":"1407_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/bjc.2017.401","volume":"118","author":"Y Kitano","year":"2018","unstructured":"Kitano Y, Okabe H, Yamashita YI, Nakagawa S, Saito Y, Umezaki N, et al. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma. Br J Cancer. 2018;118:171\u201380. https:\/\/doi.org\/10.1038\/bjc.2017.401.","journal-title":"Br J Cancer"},{"key":"1407_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109746","volume":"351","author":"X Chu","year":"2021","unstructured":"Chu X, He S, Liu Y, Liu Y, Feng F, Guo Q, et al. Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): functions, regulation, and structural insights of inhibitors. Chem Biol Interact. 2021;351:109746. https:\/\/doi.org\/10.1016\/j.cbi.2021.109746.","journal-title":"Chem Biol Interact."},{"key":"1407_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.26355\/eurrev_202312_34698","volume":"27","author":"J Kaftalli","year":"2023","unstructured":"Kaftalli J, Bonetti G, Marceddu G, Dhuli K, Maltese PE, Donato K, et al. AKR1C1 and hormone metabolism in lipedema pathogenesis: a computational biology approach. Eur Rev Med Pharmacol Sci. 2023;27:137\u201347. https:\/\/doi.org\/10.26355\/eurrev_202312_34698.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1407_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.steroids.2013.10.012","volume":"79","author":"TL Ri\u017ener","year":"2014","unstructured":"Ri\u017ener TL, Penning TM. Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism. Steroids. 2014;79:49\u201363. https:\/\/doi.org\/10.1016\/j.steroids.2013.10.012.","journal-title":"Steroids"},{"key":"1407_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108444","volume":"33","author":"CA Wohlhieter","year":"2020","unstructured":"Wohlhieter CA, Richards AL, Uddin F, Hulton CH, Quintanal-Villalonga \u00c0, Martin A, et al. Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer. Cell Rep. 2020;33:108444. https:\/\/doi.org\/10.1016\/j.celrep.2020.108444.","journal-title":"Cell Rep"},{"key":"1407_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09040-8","volume":"21","author":"D Xu","year":"2021","unstructured":"Xu D, Zhang Y, Jin F. The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining. BMC Cancer. 2021;21:1321. https:\/\/doi.org\/10.1186\/s12885-021-09040-8.","journal-title":"BMC Cancer"},{"key":"1407_CR14","doi-asserted-by":"publisher","unstructured":"Phoo N, Dejkriengkraikul P, Khaw-On P, Yodkeeree S. Transcriptomic profiling reveals AKR1C1 and AKR1C3 mediate cisplatin resistance in signet ring cell gastric carcinoma via autophagic cell death. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222212512.","DOI":"10.3390\/ijms222212512"},{"key":"1407_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cbi.2012.09.024","volume":"202","author":"T Matsunaga","year":"2013","unstructured":"Matsunaga T, Hojo A, Yamane Y, Endo S, El-Kabbani O, Hara A. Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. Chem Biol Interact. 2013;202:234\u201342. https:\/\/doi.org\/10.1016\/j.cbi.2012.09.024.","journal-title":"Chem Biol Interact"},{"key":"1407_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10528-020-10014-x","volume":"59","author":"X Wei","year":"2021","unstructured":"Wei X, Wei Z, Li Y, Tan Z, Lin C. AKR1C1 contributes to cervical cancer progression via regulating TWIST1 expression. Biochem Genet. 2021;59:516\u201330. https:\/\/doi.org\/10.1007\/s10528-020-10014-x.","journal-title":"Biochem Genet"},{"key":"1407_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2017.00119","volume":"8","author":"CM Zeng","year":"2017","unstructured":"Zeng CM, Chang LL, Ying MD, Cao J, He QJ, Zhu H, et al. Aldo-keto reductase AKR1C1-AKR1C4: functions, regulation, and intervention for anti-cancer therapy. Front Pharmacol. 2017;8:119. https:\/\/doi.org\/10.3389\/fphar.2017.00119.","journal-title":"Front Pharmacol"},{"key":"1407_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2143-7","volume":"10","author":"M Gagliardi","year":"2019","unstructured":"Gagliardi M, Cotella D, Santoro C, Cor\u00e0 D, Barlev NA, Piacentini M, et al. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. Cell Death Dis. 2019;10:902. https:\/\/doi.org\/10.1038\/s41419-019-2143-7.","journal-title":"Cell Death Dis"},{"key":"1407_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02267-2","volume":"21","author":"F Huang","year":"2021","unstructured":"Huang F, Zheng Y, Li X, Luo H, Luo L. Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer. Cancer Cell Int. 2021;21:567. https:\/\/doi.org\/10.1186\/s12935-021-02267-2.","journal-title":"Cancer Cell Int"},{"key":"1407_CR20","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife. 2014;3:e02523. https:\/\/doi.org\/10.7554\/eLife.02523.","journal-title":"Elife."},{"key":"1407_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"1407_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"key":"1407_CR23","doi-asserted-by":"publisher","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2023. https:\/\/doi.org\/10.1038\/s41580-023-00689-6.","DOI":"10.1038\/s41580-023-00689-6"},{"key":"1407_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356. https:\/\/doi.org\/10.1016\/j.cell.2023.11.044.","journal-title":"Cell"},{"key":"1407_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1407_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"1407_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023;35:84\u2013100.e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021.","journal-title":"Cell Metab"},{"key":"1407_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","volume":"86","author":"X Niu","year":"2022","unstructured":"Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC. Semin Cancer Biol. 2022;86:273\u201385. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.009.","journal-title":"Semin Cancer Biol"},{"key":"1407_CR29","doi-asserted-by":"publisher","unstructured":"Terzi EM, Sviderskiy VO, Alvarez SW, Whiten GC, Possemato R. Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5. Sci Adv. 2021;7. https:\/\/doi.org\/10.1126\/sciadv.abg4302.","DOI":"10.1126\/sciadv.abg4302"},{"key":"1407_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019;10:1617. https:\/\/doi.org\/10.1038\/s41467-019-09277-9.","journal-title":"Nat Commun"},{"key":"1407_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1346","volume":"6","author":"CC Xue","year":"2020","unstructured":"Xue CC, Li MH, Zhao Y, Zhou J, Hu Y, Cai KY, et al. Tumor microenvironment-activatable Fe-doxorubicin preloaded amorphous CaCO3 nanoformulation triggers ferroptosis in target tumor cells. Sci Adv. 2020;6:eaax1346. https:\/\/doi.org\/10.1126\/sciadv.aax1346.","journal-title":"Sci Adv"},{"key":"1407_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-020-00297-2","volume":"5","author":"C Li","year":"2020","unstructured":"Li C, Dong X, Du W, Shi X, Chen K, Zhang W, et al. LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduct Target Ther. 2020;5:187. https:\/\/doi.org\/10.1038\/s41392-020-00297-2.","journal-title":"Signal Transduct Target Ther"},{"key":"1407_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.654076","volume":"11","author":"J Nie","year":"2021","unstructured":"Nie J, Shan D, Li S, Zhang S, Zi X, Xing F, et al. A novel ferroptosis related gene signature for prognosis prediction in patients with colon cancer. Front Oncol. 2021;11:654076. https:\/\/doi.org\/10.3389\/fonc.2021.654076.","journal-title":"Front Oncol"},{"key":"1407_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.677678","volume":"11","author":"Y Gao","year":"2021","unstructured":"Gao Y, Xu D, Li H, Xu J, Pan Y, Liao X, et al. Avasimibe dampens cholangiocarcinoma progression by inhibiting FoxM1-AKR1C1 signaling. Front Oncol. 2021;11:677678. https:\/\/doi.org\/10.3389\/fonc.2021.677678.","journal-title":"Front Oncol"},{"key":"1407_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05803-2","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Yang Y, Guo Y, He J, Chen Z, Qiu S, et al. CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer. Cell Death Dis. 2023;14:271. https:\/\/doi.org\/10.1038\/s41419-023-05803-2.","journal-title":"Cell Death Dis"},{"key":"1407_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302\u20139. https:\/\/doi.org\/10.1038\/s41589-020-0472-6.","journal-title":"Nat Chem Biol"},{"key":"1407_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81:355\u201369.e10. https:\/\/doi.org\/10.1016\/j.molcel.2020.11.024.","journal-title":"Mol Cell"},{"key":"1407_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell. 2021;12:675\u20139. https:\/\/doi.org\/10.1007\/s13238-021-00823-0.","journal-title":"Protein Cell"},{"key":"1407_CR39","doi-asserted-by":"publisher","first-page":"1881393","DOI":"10.1080\/23723556.2021.1881393","volume":"8","author":"Y Ai","year":"2021","unstructured":"Ai Y, Yan B, Wang X. The oxidoreductases POR and CYB5R1 catalyze lipid peroxidation to execute ferroptosis. Mol Cell Oncol. 2021;8:1881393. https:\/\/doi.org\/10.1080\/23723556.2021.1881393.","journal-title":"Mol Cell Oncol"},{"key":"1407_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.theriogenology.2023.11.027","volume":"215","author":"H Yang","year":"2024","unstructured":"Yang H, Cai X, Qiu M, Deng C, Xue H, Zhang J, et al. Heat stress induces ferroptosis of porcine Sertoli cells by enhancing CYP2C9-Ras-JNK axis. Theriogenology. 2024;215:281\u20139. https:\/\/doi.org\/10.1016\/j.theriogenology.2023.11.027.","journal-title":"Theriogenology"},{"key":"1407_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/10815589231204058","volume":"72","author":"G Bu","year":"2024","unstructured":"Bu G, Chen G, Li J, Wu D, Liao J. Bifidobacterium bifidum BGN4 fractions ameliorate palmitic acid-induced hepatocyte ferroptosis by inhibiting SREBP1-CYP2E1 pathway. J Investig Med. 2024;72:67\u201379. https:\/\/doi.org\/10.1177\/10815589231204058.","journal-title":"J Investig Med"},{"key":"1407_CR42","doi-asserted-by":"publisher","unstructured":"Sun Y, Jin H, He J, Lai J, Lin H, Liu X. Melatonin alleviates ischemic stroke by inhibiting ferroptosis through the CYP1B1\/ACSL4 pathway. Environ Toxicol. 2024. https:\/\/doi.org\/10.1002\/tox.24136.","DOI":"10.1002\/tox.24136"},{"key":"1407_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110812","volume":"387","author":"S Yu","year":"2024","unstructured":"Yu S, Mu Y, Wang K, Wang L, Wang C, Yang Z, et al. Gestational exposure to 1-NP induces ferroptosis in placental trophoblasts via CYP1B1\/ERK signaling pathway leading to fetal growth restriction. Chem Biol Interact. 2024;387:110812. https:\/\/doi.org\/10.1016\/j.cbi.2023.110812.","journal-title":"Chem Biol Interact"},{"key":"1407_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2023.101899","volume":"68","author":"X Ma","year":"2023","unstructured":"Ma X, Xu J, Gao N, Tian J, Song T. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury via inhibiting ferroptosis by the cAMP\/PKA\/CREB pathway. Mol Cell Probes. 2023;68:101899. https:\/\/doi.org\/10.1016\/j.mcp.2023.101899.","journal-title":"Mol Cell Probes"},{"key":"1407_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153293","volume":"478","author":"M Hu","year":"2022","unstructured":"Hu M, Zhong Y, Liu J, Zheng S, Lin L, Lin X, et al. An adverse outcome pathway-based approach to assess aurantio-obtusin-induced hepatotoxicity. Toxicology. 2022;478:153293. https:\/\/doi.org\/10.1016\/j.tox.2022.153293.","journal-title":"Toxicology"},{"key":"1407_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrg.2017.47","volume":"18","author":"NJ O\u2019Neil","year":"2017","unstructured":"O\u2019Neil NJ, Bailey ML, Hieter P. Synthetic lethality and cancer. Nat Rev Genet. 2017;18:613\u201323. https:\/\/doi.org\/10.1038\/nrg.2017.47.","journal-title":"Nat Rev Genet"},{"key":"1407_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","volume":"178","author":"F Li","year":"2017","unstructured":"Li F, Zhu W, Gonzalez FJ. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther. 2017;178:18\u201330. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.03.007.","journal-title":"Pharmacol Ther"},{"key":"1407_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2017.10.013","volume":"63","author":"G D\u2019Uva","year":"2018","unstructured":"D\u2019Uva G, Baci D, Albini A, Noonan DM. Cancer chemoprevention revisited: cytochrome P450 family 1B1 as a target in the tumor and the microenvironment. Cancer Treat Rev. 2018;63:1\u201318. https:\/\/doi.org\/10.1016\/j.ctrv.2017.10.013.","journal-title":"Cancer Treat Rev"},{"key":"1407_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12478","volume":"65","author":"Z Yu","year":"2018","unstructured":"Yu Z, Tian X, Peng Y, Sun Z, Wang C, Tang N, et al. Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin-induced apoptosis in neural cancer cells. J Pineal Res. 2018;65:e12478. https:\/\/doi.org\/10.1111\/jpi.12478.","journal-title":"J Pineal Res"},{"key":"1407_CR50","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.7150\/ijbs.85883","volume":"19","author":"Q Guan","year":"2023","unstructured":"Guan Q, Wang Z, Hu K, Cao J, Dong Y, Chen Y. Melatonin ameliorates hepatic ferroptosis in NAFLD by inhibiting ER stress via the MT2\/cAMP\/PKA\/IRE1 signaling pathway. Int J Biol Sci. 2023;19:3937\u201350. https:\/\/doi.org\/10.7150\/ijbs.85883.","journal-title":"Int J Biol Sci"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01407-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01407-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:46:04Z","timestamp":1741862764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-024-01407-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1407"],"URL":"https:\/\/doi.org\/10.1038\/s41418-024-01407-1","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institutional Research Ethics Committee of Shanghai Eastern Hepatobiliary Surgery Hospital approved the study protocols and the informed consent of each patient was required (approval numbers: EHBHKY 2016-01-009, EHBHKY2018-02-014). All methods were performed in accordance with the relevant guidelines and regulations. Animal experimental procedures and protocols were approved by the Animal Care and Use Committee of Naval Medical University (approval number: 2021SLYS04).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}